clarithromycin has been researched along with Infection, Mycobacterium avium-intracellulare in 318 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.31) | 18.7374 |
1990's | 170 (53.46) | 18.2507 |
2000's | 76 (23.90) | 29.6817 |
2010's | 49 (15.41) | 24.3611 |
2020's | 22 (6.92) | 2.80 |
Authors | Studies |
---|---|
Fukushima, K; Higashiyama, Y; Hirakata, Y; Kohno, S; Kohno, Y; Miyazaki, Y; Ohno, H; Yanagihara, K | 1 |
Bader, JS; Danchik, C; Hoover, L; Karakousis, PC; Matern, WM; Parker, H | 1 |
Enoki, Y; Hasegawa, N; Iketani, O; Kizu, J; Komeya, A; Matsumoto, K; Taguchi, K; Uno, S; Uwamino, Y | 1 |
Athale, S; Bernal, C; Chapagain, M; Gumbo, T; Howe, D; Pasipanodya, JG; Trammell, R | 1 |
He, W; Li, Y; Liu, C; Ma, A; Qiu, Q; Zhao, Y | 1 |
Enoki, Y; Fukunaga, K; Hasegawa, N; Kizu, J; Matsumoto, K; Namkoong, H; Ozawa, T; Taguchi, K; Takahashi, Y; Takaya, R | 1 |
Hachisu, Y; Hisada, T; Ito, M; Koga, Y; Maeno, T; Murata, K; Sunaga, N | 1 |
Chen, J; Chen, X; Hua, W; Lin, S; Liu, H; Shao, L; Wang, S; Zhang, W; Zhang, Y | 1 |
Aoki, A; Inagaki, T; Jinno, H; Nakagawa, T; Ogawa, K; Okamoto, Y; Uchiya, KI; Wajima, T | 1 |
Chen, H; Guo, Y; Lv, H; Xu, JZ; Zhang, ZH; Zhang, ZR; Zhou, JH | 1 |
Arai, T; Inoue, Y; Kobayashi, T; Tsuyuguchi, K; Yoshida, S | 1 |
Faksri, K; Hinwan, Y; Kaewprasert, O; Sirichoat, A | 1 |
Jhun, BW; Kim, LH; Kim, SY; Lee, JM; Lee, W; Shin, SJ | 1 |
Aramaki, E; Ito, I; Iwao, T; Kato, G; Kuroda, T | 1 |
Chong, YP; Han, M; Jo, KW; Kim, OH; Kwon, BS; Kwon, YS; Lee, HY; Shim, TS | 1 |
Adachi, Y; Hayashi, S; Kagawa, T; Kobayashi, T; Kurahara, Y; Suzuki, K; Tsuyuguchi, K; Yoshida, S | 1 |
Fujita, K; Hayakawa, H; Ito, Y; Iwaizumi, E; Kanai, M; Kojima, S; Miwa, S; Ohba, H; Oshima, T; Shirai, M; Suda, T | 1 |
Chang, CL; Chen, LC; Chien, JY; Hsueh, PR; Yu, CJ | 1 |
Inoue, Y; Kimura, Y; Kobayashi, T; Kurahara, Y; Minomo, S; Suzuki, K; Tsuji, T; Tsuyuguchi, K; Yoshida, S | 1 |
Kaji, Y; Nakamura, O; Nomura, Y; Oka, K; Yamaguchi, K; Yamamoto, T | 1 |
Atsumi, J; Hiramatsu, M; Morimoto, K; Shimoda, K; Shiraishi, Y; Togo, T | 1 |
Guo, Y; Wan, B; Wang, H; Wang, W; Wu, X; Yang, J; Yu, F | 1 |
Ando, T; Kage, H; Matsumoto, Y; Nagase, T; Zokumasu, K | 1 |
Chen, HC; Huang, CC; Huang, WC; Wu, MF | 1 |
Cross, GB; Hoy, JF; Smibert, OC; Trubiano, JA | 1 |
Cadilla, AJ; Guerreiro, H; Vaz, AM; Velasco, F | 1 |
Kadota, JI; Kurashima, A; Suzuki, K; Tatsuno, K | 1 |
Hosono, Y; Kagawa, H; Kitada, S; Miki, K; Miki, M; Mori, M; Oshitani, Y; Yano, Y; Yokota, S; Yoshimura, K | 1 |
Genua, F; Lari, N; Menichini, M; Rindi, L | 1 |
Baba, T; Hagiwara, E; Isomoto, K; Katano, T; Komatsu, S; Ogura, T; Okuda, R; Otoshi, R; Sekine, A; Yamakawa, H | 1 |
Hashimoto, H; Inoue, Y; Kogure, Y; Nakagawa, T; Ogawa, K; Saito, AM; Sekimizu, M; Yagi, M | 1 |
Gumbo, T; Pasipanodya, JG | 1 |
Hong, G; Jeon, K; Jeong, BH; Kim, CK; Kim, SY; Koh, WJ; Kwon, OJ; Lee, SH; Park, HY; Shin, SJ | 1 |
Ogawa, K | 1 |
Feng, SY; Wang, HS; Wang, QL; Zhou, L | 1 |
Jeon, K; Jeong, BH; Koh, WJ; Lee, SY; Shin, SJ | 2 |
Uthman, MM; Uthman, OA; Yahaya, I | 1 |
Jeong, BH; Jeong, YJ; Kim, HJ; Koh, WJ; Lee, G; Lee, KS; Moon, JW; Woo, S | 1 |
Chida, K; Hayakawa, H; Inui, N; Masuda, M; Miwa, S; Shirai, M; Shirai, T; Suda, T; Toyoshima, M; Yamada, T; Yasuda, K; Yokomura, K | 1 |
Cho, SN; Jeon, K; Kim, SY; Koh, WJ; Kwon, OJ; Park, HY; Shin, SJ | 1 |
Brown-Elliott, BA; Griffith, DE; Killingley, J; McNulty, S; Philley, JV; Shepherd, S; Wallace, RJ; Wilson, RW; York, DS | 1 |
Caumes, E; de Masson, A; Maillart, E; Meyssonnier, V; Papeix, C; Veziris, N | 1 |
Armon, C; Baker, R; Brooks, JT; Buchacz, K; Palella, FJ; Yangco, BG | 1 |
Ihi, T; Ishii, H; Kadota, J; Komiya, K; Kudoh, S; Kurashima, A; Matsumoto, N; Mizunoe, S; Nagai, H; Ohta, K; Takahashi, O | 1 |
Field, SK; Jarand, J | 1 |
Fujita, K; Hirai, T; Ichiyama, S; Ito, Y; Kubo, T; Maekawa, K; Mishima, M; Togashi, K | 1 |
Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Ki, CS; Kim, SY; Koh, WJ; Lee, KS; Lee, NY; Park, HY; Shin, SJ | 1 |
Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Ki, CS; Kim, SY; Koh, WJ; Lee, NY; Park, HY; Shin, SJ | 1 |
Chowdhary, M; Kumar, RA; Narsinghani, U | 1 |
Abaalkhail, N; Blair, PW; Fiser, W; Herrin, D | 1 |
Akiyama, M; Betsuyaku, T; Hasegawa, N; Ishii, M; Kohno, M; Namkoong, H; Suzuki, K; Takeuchi, T; Tasaka, S; Yagi, K | 1 |
Egashira, H; Hagiwara, K; Hirama, T; Kanazawa, M; Kishi, E; Nagata, M; Nakamura, H; Shiono, A | 1 |
Akaba, T; Akagawa, S; Akashi, S; Hirose, T; Kadota, T; Kawashima, M; Kobayashi, K; Kobayashi, N; Matsui, H; Nagai, H; Ohta, K; Saito, M; Suzuki, J; Tamura, A | 1 |
Arita, M; Furuta, K; Hashimoto, T; Ishida, T; Ito, A; Ito, Y; Sone, N; Tachibana, H; Takaiwa, T; Yokoyama, T | 1 |
Betsuyaku, T; Goto, H; Hasegawa, N; Hayashi, Y; Hoshino, Y; Ishii, M; Izumi, K; Kurashima, A; Matsuda, S; Morimoto, K; Morino, E; Nakagawa, T; Namkoong, H; Nishimura, T; Ogawa, K; Sasaki, Y; Shiraishi, Y; Takasaki, J; Yoshiyama, T | 1 |
Ato, M; Hasegawa, N; Hoshino, Y; Izumi, K; Kurashima, A; Mitarai, S; Morimoto, K; Namkoong, H; Shibuya, S; Shimojima, M; Sokunaga, J; Uchimura, K; Yoshiyama, T | 1 |
Albert, A; Patel, H; Santos, MA | 1 |
Kadota, JI; Kurashima, A; Suzuki, K | 1 |
Hill, AT; Laurenson, IF; Murray, MP | 1 |
Furusyo, N; Hayashi, J; Murata, M; Ogawa, E; Ohnishi, H; Sawayama, Y; Tatsukawa, M | 1 |
East, JW; Kahlon, SS; Sarria, JC | 1 |
Hasegawa, N; Hashimoto, S; Ishizaka, A; Nakano, Y; Nishimura, M; Nishimura, T; Tasaka, S; Watabnabe, M; Yamazaki, K | 1 |
Breda, L; Chiarelli, F; de Michele, G; De Sanctis, S; Di Marzio, D; Nozzi, M | 1 |
Kobashi, Y; Oka, M | 1 |
Pereira, LH; Sterodimas, A | 1 |
Fukunaga, K; Hasegawa, N; Ishii, K; Ishizaka, A; Miyairi, M; Nishimura, T; Ohtani, S; Takeshita, K; Tasaka, S; Urano, T | 1 |
Kanekura, T; Kawai, K; Saruwatari, H; Yoshifuku, A | 1 |
Abbenyi, AT; Babady, NE; Beierle, KD; Brown-Elliott, BA; Deml, SM; Eisberner, JJ; Hall, L; McGlasson, MC; Pratt, CJ; Wallace, RJ; Wengenack, NL; Wohlfiel, SL | 1 |
Kim, CK; Kim, HJ; Lee, SH; Park, YK | 1 |
Chi, SY; Kim, EY; Kim, KS; Kim, YC; Kim, YI; Kwon, YS; Lim, SC; Oh, IJ | 1 |
Fusama, M; Hamano, Y; Higa, S; Hosokawa, T; Igarashi, T; Kamide, Y; Kawamoto, K; Kuritani, T; Kuroiwa, T; Lin, Y; Maeda, K; Nakahara, H; Nishide, M | 1 |
Aïssi, E; Ettahar, N; Huleux, T; Massongo, M; Melliez, H; Pasquet, A; Yazdanpanah, Y | 1 |
Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Miyazaki, M; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K | 1 |
Abe, M; Kato, S; Kobashi, Y; Mouri, K; Obase, Y; Oka, M | 1 |
Kubo, K; Tanabe, T; Ushiki, A; Yamazaki, Y | 1 |
Aarnoutse, RE; Boeree, MJ; Daley, CL; Egelund, EF; Heifets, LB; Levin, A; Mouton, JW; Peloquin, CA; Totten, SE; van Ingen, J | 1 |
Adler, DJ; Carlos, CA; Kovarik, CL; Tang, YW | 1 |
Abe, M; Ichiki, H; Sato, C; Ueda, S; Watanabe, A | 1 |
Schluger, NW | 1 |
Brown-Elliott, BA; Couch, L; Girard, WM; Griffith, DE; Mann, L; Wallace, RJ; Wilson, RW; Yakrus, MA; Zhang, Y | 1 |
Abe, T; Eda, R; Kobashi, Y; Kobayashi, K; Kuraoka, T; Matsushima, T; Mori, K; Moritaka, T; Nishimura, K; Ohnishi, T; Okimoto, N; Shigetou, E; Takeyama, H; Ueda, Y; Yano, S | 1 |
Batra, V; Niazi, S; Zangrilli, JG | 1 |
Campbell, J; Eskenazi, AE; Suryanarayan, K | 1 |
Dousman, L; Freund, YR; Mohagheghpour, N | 1 |
Nagai, H | 1 |
Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Wu, M; Young, LS | 1 |
Shimokata, K | 1 |
Kobashi, Y; Matsushima, T | 2 |
Forslöw, U; Geborek, A; Heurlin, N; Hjelte, L; Petrini, B | 1 |
Benson, CA; Chaisson, R; Currier, JS; Flexner, C; Hafner, R; Holland, F; Inderlied, CB; MacGregor, RR; Mahon, LF; Neidig, J; Notario, GF; Williams, PL | 1 |
Babinchak, TJ; Desimone, JA; Kaulback, KR; Pomerantz, RJ | 1 |
Anim-Appiah, D; Bono, B; Fleegler, E; Myers, AR; Roach, N; Samuel, R | 1 |
Harada, S; Harada, Y; Kitahara, Y; Mitsuyama, T; Nakanishi, Y; Yamamoto, F; Yoshida, M | 1 |
Chaisson, RE; Karakousis, PC; Moore, RD | 1 |
Ioannidis, J; Wilkinson, D | 3 |
Brunner, H; Hoffmann, T | 1 |
Bermudez, LE; Carter, G; Young, LS | 1 |
Chida, K; Hayakawa, H; Kuroishi, S; Nakano, Y; Shirai, M; Suda, T; Todate, A | 1 |
Kurashima, A | 2 |
Nakagawa, T; Ogawa, K; Taga, S; Tano, M | 1 |
Fujiwara, K | 1 |
Akaki, T; Cai, SS; Ogasawara, K; Sano, C; Sano, K; Sato, K; Shimizu, T; Tomioka, H | 1 |
Fujikane, T; Fujita, Y; Fujiuchi, S; Nishigaki, Y; Sato, M; Shimizu, T; Takeda, A; Yamamoto, Y; Yamazaki, Y | 1 |
Akagawa, S; Hebisawa, A; Kawabe, Y; Kurashima, A; Machida, K; Masuda, K; Miyamoto, M; Nagai, H; Nagayama, N; Ohashi, R; Tamura, A; Tsuchiya, K; Yotsumoto, H | 1 |
Aksamit, TR; Catanzaro, A; Daley, CL; Garay, SM; Griffith, DE; Lam, PK; Ruoss, SJ | 1 |
Asakura, K; Eguchi, K; Hasegawa, N; Horinouchi, H; Ishizaka, A; Izumi, Y; Kawamura, M; Kobayashi, K; Watanabe, M | 1 |
Brouqui, P; Lepidi, H; Moreau, J; Rolain, JM; Rovery, C; Zandotti, C | 1 |
Izumi, S; Taniguchi, H | 1 |
Alvarez, J; Brown-Elliott, BA; Caccitolo, J; Girard, W; Graviss, EA; Griffith, DE; Langsjoen, B; Nelson, K; Pan, X; Shepherd, S; Wallace, RJ; Wilson, R; Zhang, Y | 1 |
Kobashi, Y; Miyashita, N; Niki, Y; Oka, M; Yoshida, K | 1 |
Brumble, L; Garland, JL; Johnson, MM; Khoor, A; Roy, A; Waller, EA | 1 |
Bermúdez-Ruiz, P; de la Quintana-Beltrán, P; Pérez de Pedro, I | 1 |
Cefalo, E; Cugliari, M; Martín, M; Valerga, M | 1 |
Battegay, M; Burri, E; Flückiger, U; Khanlari, B; Mihatsch, F | 1 |
Käser, L; Naumann, UK; Steurer-Stey, C; Vetter, W | 1 |
Kuwabara, K; Tsuchiya, T | 1 |
Kashima, K; Nakagawa, T; Nikai, T; Ogawa, K; Saitou, Y; Taki, H; Tano, M; Tarumi, O; Yamada, N | 1 |
Cercós, A; Montero, M; Navarro, V; Santos, M | 1 |
Fujita, J; Haranaga, S; Hibiya, K; Higa, F; Tateyama, M | 1 |
Shirasaka, T | 1 |
Kurashima, A; Mikami, J; Mita, M; Nishimura, T; Ohtawa, S; Saito, M; Suzuki, A | 1 |
Faruqi, S; Kastelik, JA; McGivern, DV | 1 |
Koster, FT; Loss, SD; Mertz, GJ; Nightingale, SD | 1 |
Chin, DP; Hopewell, PC | 1 |
Baglivo, E; Bouchenaki, N; Chevalley, GF; Kaiser, L; Kress, O | 1 |
Singh, N; Yu, VL | 1 |
Cohen, Y; Grosset, J; Lazard, T; Perronne, C; Pocidalo, JJ; Vilde, JL | 1 |
Barradell, LB; McTavish, D; Plosker, GL | 1 |
Chauvin, JP; Dautzenberg, B; Diot, P; Piperno, D; Truffot-Pernot, C | 1 |
Dekio, S; Hidaka, T; Kawahara, S; Saito, H; Sato, K; Tomioka, H | 1 |
Currier, JS; Davis, RB; Ives, DV | 1 |
Danner, SA; van der Meer, JT | 1 |
Musher, DM | 1 |
Grosset, J; Ji, B; Lounis, N; Truffot-Pernot, C | 1 |
Fattorini, L; Li, B; Orefici, G; Piersimoni, C; Ricci, ML; Santoro, C; Tortoli, E; Xiao, Y | 1 |
Cohen, Y; Grosset, J; Lazard, T; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 1 |
Goldstein, EJ; Lee, D; Zarem, HA | 1 |
Tomono, K | 1 |
Heifets, L; Sanchez, T; Seay, S; Vanderkolk, J | 1 |
Cottrell, DG; Dorrell, L; Ellerton, C; Snow, MH | 1 |
Brown, BA; Girard, W; Griffith, DE; Tanaka, K; Wallace, RJ | 1 |
Benson, CA; Chaisson, RE; Craft, JC; Dube, MP; Elkin, S; Heifets, LB; Korvick, JA; Sattler, FR; Smith, T | 1 |
Goldberger, M; Masur, H | 1 |
Cynamon, MH; Grossi, MA; Klemens, SP | 1 |
Heifets, L; Mor, N; Vanderkolk, J | 1 |
Wolinsky, E | 1 |
Chauvin, JP; Dautzenberg, B; Durant, J; Legrand, MF; Meyohas, MC; Reynes, J; Saint-Marc, T; Truffot, C | 1 |
Brown, M; Brucker, AJ; Frank, I; Goldman, S; Hertle, RW; Maguire, AM; Nichols, C; Saran, BR; Van Uitert, B | 1 |
Clumeck, N; D'Abbraccio, M; D'Abraccio, M; De Mol, P; De Wit, S | 1 |
Marneff, E; Saint-Marc, T; Touraine, JL | 1 |
Brown, BA; Girard, WM; Griffith, DE; Mazurek, GH; Murphy, DT; Onyi, GO; Steingrube, VA; Wallace, RJ | 1 |
Conville, PS; Husson, RN; Inderlied, CB; Lewis, LL; Pizzo, PA; Ross, LA; Sandelli, S; Venzon, D; Witebsky, FG; Woods, L | 1 |
Benson, CA | 1 |
Deschênes, J; Miller, M; Phillips, P; Shafran, SD; Toma, E | 1 |
Green, PA; Smith, RP; von Reyn, CF | 1 |
Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 1 |
Chauvin, JP; Cotte, L; Dautzenberg, B; De Wit, S; Eliaszewitch, M; Grosset, J; Haniez, F; Meyohas, MC; Rogues, AM; Saint Marc, T | 1 |
Clark, JA; Margolis, DM | 1 |
Doucet-Populaire, F; Grosset, J; Jarlier, V; Truffot-Pernot, C | 1 |
Benson, CA; Feinberg, J; Horsburgh, CR; Ostroff, SM; Spiegel, RA | 1 |
Tseng, AL; Walmsley, SL | 1 |
Inderlied, CB; Nash, KA | 1 |
Benson, CA; Ellis, LC; Koenig, GI; Trenholme, GM | 1 |
Behling, CA; Haubrich, RH; Havlir, DV; McCutchan, JA; Torriani, FJ | 1 |
Asnis, DS; Bresciani, AR; Cohn, M | 1 |
Young, LS | 1 |
McCutchan, JA | 1 |
Craft, JC; Crampton, S; Cynamon, M; Heifets, L; Henry, D; Jablonowski, H; Jemsek, J; LaMarca, A; Montecalvo, M; Notario, G; Pierce, M; Wormser, GP; Yangco, BG | 1 |
Bates, JH | 1 |
Brown, BA; Girard, WM; Griffith, DE; Murphy, DT; Wallace, RJ | 1 |
Frothingham, R | 1 |
Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
Böttger, EC; Brown, BA; Heifets, L; Meier, A; Sander, P; Wallace, RJ; Zhang, Y | 1 |
Bollemeyer, JG; Kroon, FP; Lowe, SH; Stricker, BH; van 't Wout, JW | 1 |
Darnule, TV; Darouiche, RO; El-Zaatari, FA; Koff, A; Lidsky, MD; Rosen, T | 1 |
Bachelez, H; Dubertret, L; Ducloy, G; Pinquier, L; Rouveau, M; Sibilla, J | 1 |
Heifets, LB | 1 |
Jordan, WC | 1 |
Berger, C; Nadal, D; Pfyffer, GE | 1 |
Heifets, L | 1 |
Althaus, C; Becker, K; Schimkat, M; Sundmacher, R | 1 |
Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
Ghebremichael, S; Hoffner, SE; Källenius, G; Svenson, SB | 1 |
Bermudez, LE; Inderlied, CB; Nash, KA; Petrofsky, M; Young, LS | 1 |
Brown, BA; Griffith, DE; Wallace, RJ | 1 |
Diemer, PR; Weidle, EG; Zeh, EW | 1 |
Nelson, MR; Pozniak, A | 1 |
Brown, BA; Griffith, DE; Wallace, RJ; Warden, R | 1 |
Sakatani, M | 1 |
Tanaka, E | 1 |
Hara, K; Kuze, F; Saito, H; Sakatani, M; Shimoide, H; Soejima, R; Yamamoto, M | 1 |
Anderson, J; Helbert, M; Kelleher, P; Parkin, J; Pinching, A; Sweeney, J | 1 |
Fujii, K; Kuze, F; Ohta, K | 1 |
Block, SL; Harris, J; Kolokathis, A; Tarlow, MJ | 1 |
Benson, CA; Chaisson, RE; Craft, JC; Fessel, WJ; Keiser, P; Lahart, C; Meek, K; Pierce, M; Ruskin, J; Siepman, N | 1 |
Berning, SE; Peloquin, CA | 1 |
Ajana, F; Alfandari, S; Chidiac, C; Delaporte, E; Mouton, Y; Senneville, E | 1 |
Barbeau, P; Lapeyre, C; Leng, B; Maugein, J; Pellegrin, I; Pellegrin, JL | 1 |
Griffith, DE | 2 |
Böttger, EC; Böttger, O; Stichnoth, DO | 1 |
Brettle, RP | 1 |
Beuscart, C; Brel, F; Dautzenberg, B; Doco-Lecompte, T; Grosset, J; May, T; Perronne, C; Saint-Marc, T; Vincent, V | 1 |
Dautzenberg, B | 1 |
Cohn, DL | 1 |
Craft, JC; Fätkenheuer, G; Jablonowski, H; Lines, S; Newell, T; Youle, M | 1 |
Grosset, J; Ji, B | 1 |
Bartok, AE; Bozzette, SA; Dezfuli, MG; Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ | 1 |
Aoki, FY; Deschênes, J; Duperval, R; Lemieux, C; Miller, M; Phillips, P; Schlech, WF; Shafran, SD; Singer, J; Toma, E; Turgeon, F; Zarowny, DP | 1 |
Popov, VL; Reisner, BS; Woods, GL | 1 |
Burman, WJ; Cohn, DL; Reves, RR; Rietmeijer, CA | 1 |
Bermudez, LE; Kolonoski, P; Petrofsky, M; Young, LS | 1 |
Clumeck, N; De Wit, S; Payen, MC | 1 |
de La Blanchardiere, A; Decazes, JM; Herrmann, JL; Hocqueloux, L; Lesprit, P; Modai, J; Zagdanski, AM | 1 |
Mizutani, S | 1 |
Koster, F | 1 |
Labalette, P; Ramon, PM; Tillie-Leblond, I; Tonnel, AB; Wallaert, B | 1 |
Igual, J; Roussel, G | 1 |
Burman, WJ; Cohn, DL; Maslow, J; Reves, RR; Rietmeijer, CA; Stone, BL | 1 |
Brown, BA; Griffith, DE; Nelson, KG; Wallace, RJ | 1 |
Bayoumi, AM; Redelmeier, DA | 1 |
Aberg, JA; Jacobson, MA; Yajko, DM | 1 |
Carlson, G; Cavanaugh, J; Granneman, GR; Guenther, H; Hsu, A; Leonard, JM; Ouellet, D | 1 |
Craft, JC; Grosset, JH; Heifets, LB; Notario, GF | 1 |
Shafran, SD | 1 |
Evans, TG; Heifets, L; Huycke, M; Kauffman, C; Rimland, D; Ward, TT | 1 |
Bryan, E; McFarland, J; Sackoff, J; Su, S | 1 |
Chomyc, S; Davison, E; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Talbot, JA; Walmsley, SL | 1 |
de Lange, J; Lindeboom, JA; van den Akker, HP | 1 |
Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ | 1 |
Horgen, L; Legrand, E; Rastogi, N | 1 |
Ong, EL | 1 |
Barker, A; Chatterjee, D; Jarboe, E; Khoo, KH; Kuo, CW; Torrelles, J | 1 |
Burguière, AM; Eliaszewicz, M; Flahault, A; Fournier, S; Treilhou, MP; Vincent, V | 1 |
Berenbaum, F; Collon, T; Kaplan, G; Le Gars, L; Picard, O | 1 |
Drusano, G; Hafner, R; Inderlied, CB; Muth, K; Peterson, DM; Standiford, HC; Wright, DJ | 1 |
Chesnut, J; Child, CC; Clotfelter, J; Cohn, DL; El-Sadr, W; Fisher, EJ; Franchino, B; Gibert, CL; Hafner, R; Heifets, L; Hodges, JS; Horsburgh, CR; Korvick, J; Munroe, D; Peng, GT; Ropka, M | 1 |
Amsterdam, D; Harmon, BJ; Hewitt, RG; Hsiao, CB; Kaczmarek, SR; Papandonatos, GD; Shelton, MJ | 1 |
Cohn, DL; Gordin, FM; Horsburgh, CR; Paxton, L; Perry, K; Shafran, SD; Sullam, PM; Wynne, B | 1 |
Bucher, HC; Craig, BA; Gafni, A; Pfluger, D; Sendi, PP | 1 |
Bui, KQ; Li, C; McNabb, J; Nicolau, DP; Nightingale, CH | 1 |
Amitani, R; Kimoto, T; Kuze, F; Matsumoto, H; Murayama, T; Niimi, A; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Watanabe, I | 1 |
Kayarkar, VV; McDonnell, PJ; Tyagi, AK | 1 |
Berning, SE; Gilljam, M; Larsson, LO; Peloquin, CA; Strandvik, B | 1 |
Gidoh, M; Hidaka, T; Kobayashi, K; Kwon, HH; Murakami, K; Saito, H | 1 |
Auclair, B; Berning, SE; Huitt, GA; Peloquin, CA | 1 |
Keiser, P; Nassar, N; Rademacher, S; Skiest, D; Smith, JW | 1 |
Brown, BA; Cegielski, P; Griffith, DE; Murphy, DT; Wallace, RJ | 1 |
Guenounou, M; Matsiota-Bernard, P; Onody, C; Zinzendorf, N | 1 |
Becker, S; Benson, CA; Child, CC; Cohn, DL; Hafner, R; Heifets, L; Hojczyk, P; Korvick, JA; Lederman, MM; Nevin, T; Notario, GF; Powderly, WG; Reichman, RC; Williams, PL; Wynne, BA | 1 |
Benson, CA; Chernoff, MC; Lederman, MM; MacArthur, RD; MacGregor, RR; Mahon, LF; Purvis, S; Spritzler, J; Yen-Lieberman, B | 1 |
Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
Craven, DE; Freedberg, KA; Losina, E; Paltiel, AD; Scharfstein, JA; Seage, GR; Weinstein, MC | 1 |
Ebe, T; Sato, K | 1 |
Bermudez, LE; Inderlied, CB; Nash, K; Petrofsky, M; Young, LS | 1 |
Carter, JL; Cynamon, MH; Shoen, CM | 1 |
D'Aprile, M; Kuper, JI | 1 |
Benner, R; Bissett, J; Boulos, M; Cahn, P; Dickenson, G; Dunne, M; Fessel, J; Green, S; Hicks, C; Keiser, P; Kumar, P; Lewi, D; Mogyros, M; O'Connor, M; Schneider, MM; Tilles, J; White, AC | 1 |
Hamada, H; Hiwada, K; Kohno, N; Kondo, K; Yokoyama, A | 1 |
Benson, C; Feinberg, J; Fichtenbaum, CJ; Griffiths, JK; Zackin, R | 1 |
Akaki, T; Kawahara, S; Sato, K; Tomioka, H | 1 |
Bermudez, LE; Cangelosi, GA; Palermo, CO | 1 |
Asencio Marchante, R; Lissen Otero, E | 1 |
Benson, C | 1 |
Cheng, B | 2 |
Pierce, M | 1 |
Archange, YR; Carrey, Z; Zanlungo, PG | 1 |
Young, A | 1 |
Prescott, LM | 1 |
Currier, J | 1 |
Torres, G | 1 |
Bowersox, J | 1 |
Schouten, JT; Whittemore, S | 1 |
Bartnof, HS | 1 |
Asada, K; Inui, N; Kuwata, H; Matsuda, H; Nakamura, H; Nakamura, Y; Sennda, K; Suda, T; Suzuki, K; Tsuchiya, T; Yokomura, K | 1 |
Gomi, K; Honda, Y; Kikuchi, T; Nukiwa, T; Takahashi, H; Watanabe, A | 1 |
Hanaoka, T; Katsuragi, N; Konno, H; Nakajima, Y; Shiraishi, Y; Takasuna, K | 1 |
Gioulekas, J; Hall, A | 1 |
Binstock, P; Keating, M; Kontoyiannis, DP; Nannini, EC; Samonis, G | 1 |
Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P | 1 |
Price, TA; Tuazon, CU | 1 |
Comstock, RD; Heifets, LB; Lindholm-Levy, PJ | 1 |
Rapp, RP; Sturgill, MG | 1 |
Yajko, DM | 1 |
Chaisson, R | 1 |
Mauch, H; Ruf, B; Schürmann, D | 1 |
Berlie, HC; Chevret, S; Dautzenberg, B; Grosset, J; Legris, S; Mercat, A; Meyohas, MC; Truffot, C | 1 |
Ilic, P; Sprenger, HG; Steensma, JT; van Klingeren, B; Weits, J | 1 |
Gikas, A; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 1 |
Fernandes, PB; Hanson, CW; Hardy, DJ; McDaniel, D; Swanson, RN | 1 |
36 review(s) available for clarithromycin and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2022 |
Mycobacterium Avium Complex Infection of the Spine in a Patient Without Acquired Immune Deficiency Syndrome: A Case Report and Literature Review.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2023 |
Combined administration of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the hand caused by Mycobacterium avium complex: Case series and literature review.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Hand; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tenosynovitis | 2021 |
Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Rifabutin | 2013 |
[Nontuberculous mycobacteriosis].
Topics: Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Pneumonia, Bacterial; Prognosis; Rifampin; Streptomycin | 2003 |
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
Topics: Age Factors; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Clarithromycin; Ethambutol; HIV Infections; HIV-1; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2004 |
HIV: opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Zoster; Humans; Mycobacterium avium-intracellulare Infection; Mycoses; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
[Clinical study on development of nontuberculous mycobacterial lung disease].
Topics: Age Factors; Anti-Bacterial Agents; Asian People; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Prognosis; Severity of Illness Index; Sex Factors | 2004 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Antiviral Agents; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Famciclovir; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Mycoses; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary | 2005 |
[Perspective of pulmonary MAC infection treatment].
Topics: Aminoglycosides; Antitubercular Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Ethambutol; Evidence-Based Medicine; Humans; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Rifampin; Secondary Prevention; Time Factors; Tuberculosis, Pulmonary | 2007 |
[Mycobacterium avium intracellulare pericarditis in patients with AIDS. A case report and literature review].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Clarithromycin; Combined Modality Therapy; Ethambutol; Female; Humans; Lebanon; Mycobacterium avium-intracellulare Infection; Pericardial Effusion; Pericardiocentesis; Pericarditis; Rifabutin; Transfusion Reaction | 2007 |
[Overview of respiratory infection caused by nontuberculous mycobacteria].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Female; Humans; Immunocompromised Host; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Pulmonary | 2007 |
[Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Lymphocyte Count; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifabutin; Tuberculosis | 2007 |
Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Animals; Clarithromycin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Tuberculosis | 1993 |
Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Gentamicins; Humans; Mycobacterium avium-intracellulare Infection; Prospective Studies; Randomized Controlled Trials as Topic | 1994 |
Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Incidence; Mycobacterium avium-intracellulare Infection; Rifabutin; Risk Factors; United States | 1995 |
Rifabutin-associated uveitis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Clinical Trials as Topic; Drug Interactions; Fluconazole; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis | 1995 |
Treatment and prophylaxis of Mycobacterium avium complex.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Humans; Mice; Mycobacterium avium-intracellulare Infection | 1996 |
Clarithromycin against Mycobacterium avium complex infections.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Humans; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1996 |
Susceptibility testing of Mycobacterium avium complex isolates.
Topics: Anti-Bacterial Agents; Clarithromycin; Controlled Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1996 |
Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Survival Analysis; Treatment Outcome | 1996 |
Future indications for macrolides.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Helicobacter Infections; Humans; Malaria; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial | 1997 |
Nontuberculous mycobacteria.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 1997 |
Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Fluconazole; Humans; Immunocompromised Host; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; HIV Infections; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Controlled Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; CD4 Lymphocyte Count; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1997 |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
Topics: Activities of Daily Living; AIDS-Related Opportunistic Infections; Amikacin; Anemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cause of Death; Chemoprevention; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Fever; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Immunocompromised Host; Immunotherapy; Incidence; Interferon-gamma; Molecular Biology; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Tuberculosis; Virulence; Weight Loss | 1997 |
Pulmonary Mycobacterium avium complex disease without dissemination in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; CD4 Lymphocyte Count; Clarithromycin; Ethambutol; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Pulmonary Alveoli; Rifabutin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 1998 |
[Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Clarithromycin; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin | 1998 |
Mycobacteria as pathogens of respiratory infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; BCG Vaccine; Clarithromycin; Humans; Lung Diseases; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Mycobacterium tuberculosis; Protease Inhibitors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
Prophylaxis against disseminated Mycobacterium avium complex in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clarithromycin; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1999 |
Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease.
Topics: Azithromycin; Clarithromycin; Drug Interactions; HIV Protease Inhibitors; Humans; Mycobacterium avium-intracellulare Infection; Reverse Transcriptase Inhibitors; Rifabutin | 2000 |
Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Interactions; Erythromycin; Humans; Macrophages; Mycobacterium avium-intracellulare Infection; Respiratory Tract Infections; Skin Diseases, Infectious | 1992 |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Macrophages; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1992 |
64 trial(s) available for clarithromycin and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Toxic Optic Neuropathy | 2021 |
Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic
Topics: Adult; Aged; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quality of Life; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome; Young Adult | 2019 |
Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Clarithromycin; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Logistic Models; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Practice Guidelines as Topic; Republic of Korea; Retrospective Studies; Rifampin; Sputum | 2015 |
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome | 2012 |
Infection fighters. MAC prevention takes a holiday.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Placebos; Viral Load | 2000 |
The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Prospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2003 |
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin | 2003 |
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Bronchiectasis; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Forced Expiratory Flow Rates; Forced Expiratory Volume; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2006 |
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Radiography; Treatment Outcome | 2006 |
Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prospective Studies; Treatment Outcome | 1995 |
[Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis].
Topics: Aged; Aged, 80 and over; Animals; Chronic Disease; Clarithromycin; Female; Humans; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium avium-intracellulare Infection; Tuberculosis, Pulmonary | 1994 |
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Survival Analysis | 1994 |
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Child; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Hearing Disorders; Humans; Liver Function Tests; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Recurrence; Treatment Outcome | 1994 |
[Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chemical and Drug Induced Liver Injury; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1993 |
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Sputum; Tuberculosis, Pulmonary | 1994 |
Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome.
Topics: Administration, Oral; Adolescent; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recurrence | 1994 |
Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Jaundice; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Uveitis | 1994 |
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1993 |
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Disease-Free Survival; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Survival Analysis | 1996 |
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Protein Synthesis Inhibitors; Rifabutin; Rifampin; Streptomycin; Treatment Outcome | 1996 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (1) Continuous positive cases (failure of the initial chemotherapy)].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Pilot Projects; Retrospective Studies; Treatment Failure; Tuberculosis, Pulmonary | 1996 |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Mycobacterium avium-intracellulare Infection; Ofloxacin; Pilot Projects; Rifampin; Tuberculosis, Pulmonary | 1996 |
[The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Treatment Outcome; Tuberculosis, Pulmonary | 1997 |
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection | 1997 |
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence; Rifabutin | 1997 |
Ancillary benefits of Mycobacterium avium-intracellulare complex prophylaxis with clarithromycin in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; CD4 Lymphocyte Count; Clarithromycin; Female; Giardia lamblia; Giardiasis; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumocystis; Pneumonia; Pneumonia, Pneumocystis; Sarcoma, Kaposi | 1997 |
A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence | 1997 |
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium-intracellulare Infection; Rifabutin; Risk Factors; Uveitis | 1998 |
Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lamivudine; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Stavudine; Zidovudine | 1998 |
Pharmacokinetic interaction between ritonavir and clarithromycin.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Female; Half-Life; HIV Protease Inhibitors; Humans; Hydroxylation; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Reference Values; Ritonavir | 1998 |
Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies | 1998 |
Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Time Factors; Treatment Outcome | 1998 |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Dapsone; Ethnicity; Female; HIV Infections; Humans; Longitudinal Studies; Male; Medical Records; Mycobacterium avium-intracellulare Infection; Naphthoquinones; New York City; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Regression Analysis; Rifabutin; Risk-Taking; Time Factors; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Public Health Service | 1998 |
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Predictive Value of Tests; Rifabutin | 1998 |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1999 |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
Topics: Aged; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis | 1999 |
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Resear
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Patient Compliance; Prospective Studies; Rifabutin; Survivors; Treatment Outcome | 1999 |
A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Survival Analysis | 1999 |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Cross-Over Studies; Female; Half-Life; Humans; Leukocytes, Mononuclear; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Neutrophils | 1999 |
Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Ethambutol; Female; Fluoroquinolones; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Survival Analysis; Treatment Outcome | 1999 |
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; HIV Seronegativity; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Sputum; Treatment Outcome | 2000 |
Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Cell Line; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Monocytes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nucleic Acid Hybridization; Random Amplified Polymorphic DNA Technique; Recurrence; Tumor Necrosis Factor-alpha | 2000 |
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Progra
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin | 2000 |
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Cytokines; Ethambutol; Humans; Interleukin-1; Interleukin-6; Mycobacterium avium-intracellulare Infection; Pilot Projects; Rifabutin; RNA, Viral; Tumor Necrosis Factor-alpha; Viral Load | 2000 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
[A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Time Factors; Treatment Outcome | 2000 |
A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Gastrointestinal Diseases; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis; Treatment Outcome | 2000 |
Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Child; Clarithromycin; Cryptosporidiosis; Cryptosporidium parvum; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 2000 |
Clarithromycin for MAC.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1995 |
Clarithromycin and MAC.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Humans; Mycobacterium avium-intracellulare Infection; Prospective Studies | 1996 |
Different clarithromycin doses affect mortality.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate | 1997 |
Abbott files SNDA for MAC prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; HIV Infections; Humans; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Placebos; Randomized Controlled Trials as Topic | 1995 |
Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antiviral Agents; CD4 Lymphocyte Count; Clarithromycin; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic | 1995 |
Researchers find new drugs to fight MAC.
Topics: AIDS-Related Opportunistic Infections; Animals; Antitubercular Agents; CD4 Lymphocyte Count; Clarithromycin; Half-Life; Humans; Mycobacterium avium-intracellulare Infection; Placebos; Randomized Controlled Trials as Topic; Rifabutin; Rifampin | 1995 |
FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Clinical Trials as Topic; Drug Approval; Humans; Mycobacterium avium-intracellulare Infection; Placebos; Randomized Controlled Trials as Topic; United States Food and Drug Administration | 1995 |
Antivirals key to MAC prevention regimen.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Azithromycin; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Rifabutin | 1996 |
[Roxithromycin therapy of patients with mycobacterium avium complex lung infection].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Roxithromycin; Treatment Outcome; Tuberculosis, Pulmonary | 2001 |
New antibiotics look good against M. avium.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Erythromycin; Humans; Mycobacterium avium-intracellulare Infection | 1992 |
Clarithromycin is effective against M. avium complex in AIDS.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1992 |
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1991 |
218 other study(ies) available for clarithromycin and Infection, Mycobacterium avium-intracellulare
Article | Year |
---|---|
In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
Topics: Animals; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Japan; Levofloxacin; Liver; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolines; Spleen | 2007 |
Genetic Determinants of Intrinsic Antibiotic Tolerance in Mycobacterium avium.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA Transposable Elements; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Humans; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 2021 |
Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2022 |
Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tetracyclines | 2022 |
Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China.
Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Rifabutin | 2022 |
Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system.
Topics: Clarithromycin; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Japan; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2022 |
In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clofazimine; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 2022 |
A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Leprostatic Agents; Lung Diseases; Macrolides; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis | 2023 |
Cases of severe Mycobacterium avium lung disease occurred in a married couple caused by identical strain.
Topics: Aged; Clarithromycin; Female; Humans; Lung Diseases; Male; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2023 |
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phylogeny; Thailand | 2023 |
Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Humans; Lung Diseases; Macrolides; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones | 2023 |
A survey of clarithromycin monotherapy and long-term administration of ethambutol for patients with MAC lung disease in Japan: A retrospective cohort study using the database of health insurance claims.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Cohort Studies; Databases, Factual; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Infant; Infant, Newborn; Insurance Claim Review; Japan; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Surveys and Questionnaires; Young Adult | 2020 |
Discontinuation rates attributed to adverse events and treatment outcomes between clarithromycin and azithromycin in Mycobacterium avium complex lung disease: A propensity score analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Humans; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Propensity Score; Retrospective Studies; Treatment Outcome | 2020 |
Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prognosis; Respiratory Tract Infections; Retrospective Studies; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Japan; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Negative Results; Pneumonia, Bacterial; Rifampin | 2020 |
Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Taiwan; Young Adult | 2020 |
Resumption/efficacy and safety of an azithromycin-containing regimen against Mycobacterium avium complex lung disease in patients who experienced adverse effects with a clarithromycin-containing regimen.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2021 |
A Novel Approach to Extensive Clarithromycin-Resistant Mycobacterium avium Complex Pulmonary Disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Female; Humans; Lung Diseases; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 2022 |
Difference in drug susceptibility distribution and clinical characteristics between
Topics: Adult; Aged; Anti-Bacterial Agents; China; Ciprofloxacin; Clarithromycin; Cough; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Lung; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography; Sputum | 2021 |
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin | 2018 |
Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 2017 |
Capsule endoscopy in the diagnosis of disseminated
Topics: Abdominal Pain; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Capsule Endoscopy; CD4 Lymphocyte Count; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fever; HIV Infections; Humans; Intestinal Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Treatment Outcome; Vomiting | 2017 |
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance.
Topics: Age Factors; Aged; Clarithromycin; Female; Humans; Japan; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Product Surveillance, Postmarketing; Sex Factors | 2018 |
The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Sputum; Time Factors | 2018 |
Genotyping and clarithromycin susceptibility testing of Mycobacterium avium subsp. hominissuis isolated in Tuscany, Italy.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Female; Genotype; Humans; Infant; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2018 |
Clinical characteristics and early outcomes of patients newly diagnosed with pulmonary Mycobacterium avium complex disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antibodies, Bacterial; Biomarkers; Clarithromycin; Female; Humans; Immunoglobulin A; Incidental Findings; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Retrospective Studies; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2019 |
Drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Monitoring; Female; Humans; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2013 |
Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Resistance, Bacterial; Ethambutol; Female; Fluoroquinolones; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines; Rifampin; Sputum | 2013 |
Genetic research about Mycobacterium avium complex.
Topics: Clarithromycin; Drug Resistance, Bacterial; Genotype; Humans; Minisatellite Repeats; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tandem Repeat Sequences; Tuberculosis, Pulmonary | 2013 |
Cutaneous Mycobacterium intracellulare infection in an immuno-competent person.
Topics: Adult; Antitubercular Agents; Bacterial Proteins; Chaperonin 60; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Skin; Skin Diseases, Bacterial | 2013 |
Reply: drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Monitoring; Female; Humans; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2013 |
Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Middle Aged; Multiple Pulmonary Nodules; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Proportional Hazards Models; Retrospective Studies; Rifampin; Tomography, X-Ray Computed | 2013 |
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin; Th1 Cells; Th17 Cells; Th2 Cells | 2014 |
Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Follow-Up Studies; Genotype; Humans; Lung Diseases; Macrolides; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Sputum; Treatment Outcome | 2014 |
Cavitary pulmonary disease in a patient treated with natalizumab.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Multiple Sclerosis, Relapsing-Remitting; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Natalizumab; Pneumonia, Bacterial | 2014 |
Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antibiotic Prophylaxis; Antiretroviral Therapy, Highly Active; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; RNA, Viral; United States; Viral Load | 2014 |
Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Propensity Score; Retrospective Studies; Treatment Outcome | 2014 |
Embrace simplicity when treating lady windermere.
Topics: Azithromycin; Bronchiectasis; Clarithromycin; Female; Humans; Lung Diseases; Macrolides; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2014 |
The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Environmental Exposure; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recurrence; Retrospective Studies; Rifampin; Soil Microbiology; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
Topics: Aged; Anti-Bacterial Agents; Bronchiectasis; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum | 2015 |
Intracranial abscess due to Mycobacterium avium complex in an immunocompetent host: a case report.
Topics: Adult; Anti-Bacterial Agents; Brain Abscess; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2015 |
DRESS syndrome presenting after initiation of mycobacterium avium complex osteomyelitis treatment.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Hypersensitivity Syndrome; Ethambutol; Humans; Liver Function Tests; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Prednisone; Rifabutin; Treatment Outcome | 2015 |
Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Immunocompromised Host; Lung; Middle Aged; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Rifampin; Tomography, X-Ray Computed | 2015 |
PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sensitivity and Specificity; Sputum | 2016 |
Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; C-Reactive Protein; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Risk Factors; Serum Albumin; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Confidence Intervals; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Respiratory Tract Infections; Retrospective Studies | 2016 |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Female; Humans; Inappropriate Prescribing; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Diseases; Macrolides; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Multidrug-Resistant | 2016 |
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
Topics: Age Distribution; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Female; Humans; Japan; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Prevalence; Sex Distribution; Tuberculosis, Pulmonary | 2017 |
Nothing to (S)cough at: Pulmonary Mycobacterium avium Complex Infection.
Topics: Anti-Bacterial Agents; Bronchiectasis; Chest Pain; Clarithromycin; Cough; Drug Therapy, Combination; Dyspnea; Ethambutol; Humans; Leukocytosis; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tracheobronchomegaly; Veterans | 2017 |
The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Marketing; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Sputum; Treatment Outcome | 2017 |
[AIDS-related Mycobacterium avium infection dissemination in a patient with endobronchial lesions associated with immune reconstitution inflammatory syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Bronchial Diseases; Bronchitis; Clarithromycin; Female; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Mycobacterium avium-intracellulare Infection; Streptomycin; Treatment Outcome | 2008 |
Mycobacterium-avium-intracellulare complex immune reconstitution inflammatory syndrome in HIV/AIDS presenting as osteomyelitis.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Rifabutin; Viral Load | 2008 |
Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease.
Topics: Aged; Algorithms; Anti-Bacterial Agents; Biotransformation; Body Fluids; Body Mass Index; Bronchoscopy; Clarithromycin; Epithelium; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium-intracellulare Infection | 2009 |
Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children.
Topics: Anti-Bacterial Agents; Arthralgia; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunocompetence; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Rifampin; Treatment Outcome | 2009 |
[Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Recurrence; Rifampin; Sputum; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2008 |
Autologous fat transplantation and delayed silicone implant insertion in a case of Mycobacterium avium breast infection.
Topics: Adipose Tissue; Anti-Bacterial Agents; Breast Diseases; Breast Implantation; Breast Implants; Clarithromycin; Female; Humans; Mastectomy; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Prosthesis Failure; Reoperation; Silicone Gels; Transplantation, Autologous; Treatment Outcome | 2010 |
Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchiectasis; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Cutaneous Mycobacterium intracellulare infection in a bone marrow transplantation recipient.
Topics: Bone Marrow Transplantation; Clarithromycin; Graft vs Host Disease; Humans; Immunocompromised Host; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tuberculosis, Cutaneous; Vasculitis; Young Adult | 2010 |
Evaluation of Mycobacterium avium complex clarithromycin susceptibility testing using SLOMYCO Sensititre panels and JustOne strips.
Topics: Antitubercular Agents; Clarithromycin; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2010 |
Isolation and characterizations of clarithromycin-resistant Mycobacterium avium clinical isolates.
Topics: Anti-Bacterial Agents; Clarithromycin; DNA Mutational Analysis; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nucleic Acid Hybridization; Point Mutation; Republic of Korea; RNA, Ribosomal, 23S | 2011 |
Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Treatment Outcome | 2011 |
A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome | 2011 |
[Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Axilla; Clarithromycin; Darunavir; Dideoxynucleosides; Enfuvirtide; Ethambutol; HIV Envelope Protein gp41; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Lamivudine; Lymph Node Excision; Lymphadenitis; Male; Mycobacterium avium-intracellulare Infection; Peptide Fragments; Pyrazinamide; Rifampin; Ritonavir; Streptomycin; Sulfonamides | 2011 |
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
Topics: Aged; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
[Analysis of inflammatory substances associated with intracellular amplification of Mycobacterium avium BEAS-2B cells and suppressive effects of clarithromycin].
Topics: Anti-Bacterial Agents; Bronchi; Clarithromycin; Humans; In Vitro Techniques; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Respiratory Mucosa | 2009 |
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
Topics: Adult; Aged; Amikacin; Antibiotics, Antitubercular; Area Under Curve; Clarithromycin; Cohort Studies; Colorado; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Retrospective Studies; Rifabutin; Rifampin | 2012 |
Mycobacterial infection identified with broad-range PCR amplification and suspension array identification.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Immunocompetence; Microarray Analysis; Molecular Diagnostic Techniques; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; Rifabutin; Skin Diseases, Infectious; Thumb; Treatment Outcome | 2012 |
Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Logistic Models; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Republic of Korea; Retrospective Studies; Rifabutin; Rifampin | 2012 |
[A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary | 2012 |
Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Monitoring; Female; Humans; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2012 |
Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; Prospective Studies; Sputum | 2002 |
[Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Retrospective Studies; Treatment Outcome | 2002 |
Atypical mycobacterial osteomyelitis in a non-AIDS patient.
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Middle Aged; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Rifampin; Thoracic Vertebrae | 2002 |
Nontuberculous mycobacterial infections in pediatric acute leukemia.
Topics: Child, Preschool; Clarithromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rifampin | 2002 |
Prophylactic clarithromycin to treat mycobacterium avium in HIV patients receiving zidovudine may significantly increase mortality by suppressing lymphopoiesis and hematopoiesis.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Cell Line; Clarithromycin; Dose-Response Relationship, Drug; Female; Hematopoiesis; HIV Infections; Humans; Lymphocyte Activation; Lymphopoiesis; Mice; Mice, Inbred BALB C; Mycobacterium avium-intracellulare Infection; Zidovudine | 2002 |
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Aza Compounds; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mefloquine; Mice; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines | 2003 |
Treatment of pulmonary disease caused by Mycobacterium avium complex.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2003 |
Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Child; Clarithromycin; Cohort Studies; Cystic Fibrosis; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Rifampin; Streptomycin | 2003 |
Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Ciprofloxacin; Clarithromycin; Decision Trees; Diagnosis, Differential; HIV-1; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography | 2003 |
Mycobacterium avium complex tenosynovitis of the wrist and hand.
Topics: Adult; Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Magnetic Resonance Imaging; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Tenosynovitis; Treatment Outcome; Wrist | 2004 |
Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Outcome Assessment, Health Care; Practice Guidelines as Topic; Rifampin; Saliva; Sex Distribution; Streptomycin | 2004 |
Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Female; Humans; Liver; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Time Factors | 2004 |
Model for simulation of HIV/AIDS and cost-effectiveness of preventing non-tuberculous mycobacterial (MAC)-disease.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Health Care Costs; Humans; Models, Economic; Mycobacterium avium-intracellulare Infection; Protease Inhibitors; Quality-Adjusted Life Years; Rifabutin | 2004 |
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Biofilms; Clarithromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines | 2004 |
[Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prognosis; Retrospective Studies; Sputum; Treatment Outcome | 2004 |
[The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Ofloxacin; Radiography, Thoracic; Retrospective Studies; Streptomycin | 2005 |
[A case of Mycobacterium intracellulare lung disease that was detected by health examination and was successfully cured by chemotherapy--including discussions on the diagnostic criteria of the disease].
Topics: Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Magnetic Resonance Imaging; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tomography, X-Ray Computed | 2005 |
Combined effects of ATP on the therapeutic efficacy of antimicrobial drug regimens against Mycobacterium avium complex infection in mice and roles of cytosolic phospholipase A2-dependent mechanisms in the ATP-mediated potentiation of antimycobacterial hos
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Base Sequence; Clarithromycin; Cytokines; Cytosol; Drug Synergism; Macrophages; Mice; Mice, Inbred BALB C; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phospholipases A; Phospholipases A2; Rifamycins; RNA, Messenger; Signal Transduction | 2005 |
Efficacy and outcomes of clarithromycin treatment for pulmonary MAC disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2005 |
[Case of pulmonary mycobacterium avium complex disease, showing hypersensitivity pneumonitis-like diffuse shadow].
Topics: Alveolitis, Extrinsic Allergic; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prednisolone; Steam Bath; Treatment Outcome; Tuberculosis, Pulmonary; Water Microbiology | 2006 |
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchiectasis; Case Management; Clarithromycin; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Quinolones; Sputum; Thoracoplasty; Time Factors; Treatment Outcome | 2006 |
Bartonella quintana coinfection with Mycobacterium avium complex and CMV in an AIDS patient: case presentation.
Topics: AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; Anti-Bacterial Agents; Antibodies, Viral; Bartonella quintana; Biopsy; Clarithromycin; Cytomegalovirus; Cytomegalovirus Infections; Dermatologic Surgical Procedures; Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Skin; Treatment Outcome | 2006 |
[A case of Mycobacterium intracellulare infection with chronic empyema].
Topics: Aged, 80 and over; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Empyema; Ethambutol; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifampin; Streptomycin; Tomography, X-Ray Computed | 2006 |
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Chaperonin 60; Chaperonins; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial; Polymerase Chain Reaction; Prognosis; Retrospective Studies; RNA, Bacterial | 2006 |
The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.
Topics: Adult; Amikacin; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Granuloma; Humans; Lung; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Prednisone; Rifampin; Sputum; Tomography, X-Ray Computed | 2006 |
[Cervical lymphadenitis due to Mycobacterium avium in an immunocompetent adult].
Topics: Accidents, Traffic; Adolescent; Ciprofloxacin; Clarithromycin; Ethambutol; Humans; Immunocompetence; Lymphadenitis; Male; Mouth; Mycobacterium avium-intracellulare Infection; Neck; Wound Infection | 2007 |
[Mycobacterium avium infection in a renal transplant recipient].
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Biopsy; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Ethambutol; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Hepatic; Typhlitis | 2007 |
[Mycobacterium avium pneumonia in an HIV negative patient].
Topics: Aged; Bronchoscopy; Clarithromycin; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Rifabutin; Tomography, X-Ray Computed | 2007 |
[Brochiectasis (in the adult)].
Topics: Adult; Aged; Aza Compounds; Bronchiectasis; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Immunization, Passive; Immunoglobulin M; Male; Moxifloxacin; Mycobacterium avium-intracellulare Infection; Paraproteinemias; Quinolines; Rifabutin; Tomography, X-Ray Computed; Waldenstrom Macroglobulinemia | 2007 |
[Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
Topics: Aged; Bronchiectasis; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2007 |
[Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Interactions; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Tuberculosis, Pulmonary | 2007 |
[Clinical efficacy of kanamycin for Mycobacterium avium complex disease].
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin | 2008 |
Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA.
Topics: Antibiotics, Antitubercular; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Thoracic Surgery, Video-Assisted; Tuberculosis, Pulmonary; Vasculitis | 2008 |
Clarithromycin-induced mania in two patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Bipolar Disorder; Clarithromycin; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1995 |
How to treat bacteraemic Mycobacterium avium complex disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Rifabutin; Survival Rate; Treatment Outcome | 1995 |
[Uveitis associated with rifabutin treatment. Apropos of 3 patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis, Anterior | 1995 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.
Topics: Acquired Immunodeficiency Syndrome; Animals; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Female; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mifepristone; Mycobacterium avium-intracellulare Infection; Recombinant Proteins; Spleen | 1993 |
Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rifamycins; Streptomycin | 1995 |
Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex.
Topics: Adult; AIDS-Related Opportunistic Infections; Azithromycin; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Survival Rate | 1995 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.
Topics: Amikacin; Animals; Clarithromycin; Drug Resistance, Microbial; Ethambutol; Female; Humans; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Spleen | 1995 |
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.
Topics: Amikacin; Clarithromycin; Drug Therapy, Combination; Humans; In Vitro Techniques; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1995 |
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Female; Glucocorticoids; Humans; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mifepristone; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen | 1995 |
Localized Mycobacterium avium-intracellulare mastitis in an immunocompetent woman with silicone breast implants.
Topics: Adult; Breast Implants; Clarithromycin; Female; Humans; Mastitis; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Prosthesis Failure; Silicones | 1995 |
Quantitation of mycobacteria in blood specimens from patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Blood Preservation; Clarithromycin; Colony Count, Microbial; Culture Media; Dose-Response Relationship, Drug; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Time Factors | 1994 |
Toxicity of clarithromycin in the treatment of Mycobacterium avium complex infection in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Corneal Opacity; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1994 |
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection.
Topics: Clarithromycin; Drug Interactions; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin | 1995 |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1994 |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice.
Topics: Animals; Azithromycin; Clarithromycin; Culture Media; Disease Models, Animal; Female; Lung; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen | 1994 |
Mycobacterium avium strains resistant to clarithromycin and azithromycin.
Topics: Azithromycin; Clarithromycin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1993 |
Mycobacterium avium strains resistant to clarithromycin and azithromycin.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1994 |
Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents; Child; Clarithromycin; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Iridocyclitis; Male; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; Suppuration; Uveitis, Anterior | 1994 |
Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Mycobacterium avium; Mycobacterium avium-intracellulare Infection | 1993 |
AIDS patients have a new weapon against MAC infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Child; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; United States; United States Food and Drug Administration | 1994 |
Antibiotic gets FDA nod for MAC treatment.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1994 |
Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol.
Topics: Child; Clarithromycin; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Ethambutol; Humans; Lymphadenitis; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Parotitis | 1993 |
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Ethambutol; Evaluation Studies as Topic; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones | 1993 |
Clarithromycin effectively treats infection in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic | 1993 |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Skin Diseases, Bacterial | 1993 |
Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Bacterial Agents; Base Sequence; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Peptidyl Transferases; Ribosomes; RNA, Messenger | 1995 |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Base Sequence; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nucleic Acid Conformation; Operon; Polymerase Chain Reaction; RNA, Bacterial; RNA, Messenger; RNA, Ribosomal, 23S | 1995 |
Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Interactions; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1995 |
Disseminated Mycobacterium avium complex: correlation between blood and tissue burden.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Autopsy; Bacteremia; Clarithromycin; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Tissue Distribution | 1996 |
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Pulmonary Atelectasis; Rifampin | 1996 |
Azithromycin in the prophylaxis of opportunistic infections in AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Clarithromycin; Clinical Trials as Topic; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Mycobacterium avium disease: progress at last.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Protein Synthesis Inhibitors | 1996 |
Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Humans; Lung Diseases; Mycobacterium avium-intracellulare Infection; Protein Synthesis Inhibitors | 1996 |
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population.
Topics: Base Sequence; Clarithromycin; DNA, Ribosomal; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Humans; Molecular Sequence Data; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 1996 |
Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis | 1996 |
Recurrent disseminated infection with Mycobacterium avium complex identified in tissues by molecular analysis.
Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Ethambutol; Humans; Male; Mycobacterium avium-intracellulare Infection; Polymerase Chain Reaction; Skin Diseases, Bacterial; Synovial Membrane | 1996 |
Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Male; Mycobacterium avium-intracellulare Infection; Skin Diseases, Bacterial | 1996 |
Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; CD4 Lymphocyte Count; Clarithromycin; Cryptosporidiosis; Humans; Mycobacterium avium-intracellulare Infection; Retrospective Studies | 1996 |
Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Infant; Lymph Node Excision; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Tooth Discoloration; Tuberculosis, Lymph Node | 1996 |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus.
Topics: Acute Disease; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluconazole; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis, Anterior; Visual Acuity | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Antimycobacterial synergism of clarithromycin and rifabutin.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Three new studies expand understanding of MAC therapy.
Topics: Azithromycin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis | 1996 |
Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Genes, Bacterial; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutagenesis, Site-Directed; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Ribosomal, 23S; Spleen | 1996 |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease.
Topics: Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV; Humans; Leukocyte Count; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Platelet Count; Rifabutin | 1996 |
[Rifabutin-induced hypopyon iritis in HIV infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Iritis; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Clarithromycin-associated digoxin toxicity in the elderly.
Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Atrial Fibrillation; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Echocardiography; Ethambutol; Humans; Male; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Uveitis associated with rifabutin and macrolide therapy for Mycobacterium avium intracellulare infection in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; Uveitis | 1996 |
Multiple primary Mycobacterium avium infection of the skin.
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Female; Humans; Mycobacterium avium-intracellulare Infection; Tuberculosis, Cutaneous | 1997 |
[Management of atypical Mycobacterium infections in AIDS-patients].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Advice on treatment of Mycobacterium avium complex infection.
Topics: Antitubercular Agents; Clarithromycin; Drug Interactions; Humans; Isoniazid; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifamycins | 1997 |
Isolated cutaneous Mycobacterium avium complex infection in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Mycobacterium avium-intracellulare Infection; Skin Diseases, Bacterial | 1997 |
Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Rifabutin | 1996 |
Prophylaxis of mycobacterial infection and acquired drug resistance.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Drug Resistance, Microbial; Gastrointestinal Diseases; Humans; Models, Biological; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin.
Topics: Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteremia; Blood Transfusion; Clarithromycin; Colorado; Community Health Centers; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Survival Rate; Treatment Outcome | 1997 |
Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Female; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen | 1998 |
Paradoxical local response to therapy for Mycobacterium avium complex infection in four patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Clarithromycin; Hepatomegaly; Humans; Lymph Nodes; Male; Mycobacterium avium-intracellulare Infection | 1998 |
[Uveitis, arthralgia and pseudo-jaundice in a HIV seronegative patient due to rifabutin].
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Arthralgia; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Female; HIV Seronegativity; Humans; Jaundice; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis | 1998 |
Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Time Factors; Treatment Outcome | 1998 |
Results of operation in Mycobacterium avium-intracellulare lung disease.
Topics: Adult; Aged; Antitubercular Agents; Blood Loss, Surgical; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Postoperative Complications; Recurrence; Reoperation; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Azithromycin; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Health Care Costs; HIV Infections; HIV Protease Inhibitors; Humans; Male; Markov Chains; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quality of Life; Rifabutin; United States | 1998 |
Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Rate | 1998 |
Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections.
Topics: Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Female; Humans; Infant; Lymphatic Diseases; Mycobacterium avium-intracellulare Infection; Neck | 1999 |
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
Topics: AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiometry; Rifampin | 1999 |
Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Cell Wall; Chromatography, Thin Layer; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Ethambutol; Galactans; Glycoconjugates; Humans; Lipopolysaccharides; Mass Spectrometry; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polysaccharides; Polysaccharides, Bacterial; Surface Properties | 1999 |
Polyarthralgia-arthritis syndrome induced by low doses of rifabutin.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Arthralgia; Arthritis; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin; Syndrome | 1999 |
Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Biopsy; Blood; Bone Marrow; Clarithromycin; Colony Count, Microbial; Culture Media; Ethambutol; Female; HIV-1; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Viral | 1999 |
Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Blood; Clarithromycin; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin | 1999 |
Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort Study.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Computer Simulation; Disease Progression; Economics, Pharmaceutical; HIV Infections; Humans; Markov Chains; Mycobacterium avium-intracellulare Infection; Probability; Randomized Controlled Trials as Topic; Reproducibility of Results; Risk Factors; Switzerland | 1999 |
An unreported side effect of topical clarithromycin when used successfully to treat Mycobacterium avium-intracellulare keratitis.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Clarithromycin; Cornea; Corneal Diseases; Corneal Ulcer; Eye Infections, Bacterial; Humans; Male; Mycobacterium avium-intracellulare Infection | 1999 |
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease.
Topics: Adolescent; Adult; Antitubercular Agents; Biological Availability; Clarithromycin; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mycobacterium avium-intracellulare Infection; Pregnancy; Rifampin; Tuberculosis, Pulmonary | 1999 |
[Chemoprophylaxis against Mycobacterium avium complex infection induced in mice].
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Female; Mice; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifamycins | 1999 |
Potential interaction between itraconazole and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1999 |
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; CD4 Lymphocyte Count; Ciprofloxacin; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Longitudinal Studies; Male; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Time Factors | 1999 |
The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Quality-Adjusted Life Years; Rifabutin | 1999 |
Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Microbial; Ethambutol; Humans; In Vitro Techniques; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Ribosomal, 23S | 2000 |
Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.
Topics: Animals; Anti-Bacterial Agents; Cell Count; Clarithromycin; Erythromycin; Ketolides; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen | 2000 |
[A case of pneumonia caused by Mycobacterium avium complex successfully treated with clarithromycin].
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial | 2000 |
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
Topics: Anti-Bacterial Agents; Cell Line; Clarithromycin; Epithelial Cells; Humans; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Ofloxacin; Pulmonary Alveoli; Rifamycins; Tuberculosis | 2000 |
Phenotypic consequences of red-white colony type variation in Mycobacterium avium.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Congo Red; Drug Resistance, Microbial; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phenotype; Pigments, Biological; Rifampin; Virulence | 2001 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Antitubercular Agents; Antiviral Agents; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ethambutol; Ganciclovir; Humans; Leucovorin; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Rifabutin; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis; Trimethoprim | 2001 |
NIAID study rules out high-dose clarithromycin for AIDS-related MAC.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; Survival Analysis | 1996 |
New data suggest antibiotic clarithromycin is effective in prolonging life of AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; Quality of Life; Survival Rate | 1996 |
Advances in the diagnosis and treatment of Mycobacterium avium complex (MAC) disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bone Marrow; Clarithromycin; Drug Therapy, Combination; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1994 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |
Another perspective on MAC prophylaxis. Interview by Gordon Nary.
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; CD4 Lymphocyte Count; Clarithromycin; Drug Approval; Drug Resistance, Microbial; HIV Infections; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; United States; United States Food and Drug Administration | 1995 |
Physician's aggressive preventive therapy differs.
Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Clarithromycin; Cytomegalovirus Infections; Ethambutol; Humans; Meningitis, Cryptococcal; Mycobacterium avium-intracellulare Infection; New York City; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
New drug applications sought.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Cytomegalovirus Retinitis; Drug Approval; Drug Implants; Drug Labeling; Foscarnet; Ganciclovir; Herpes Simplex; HIV Infections; Infusions, Intravenous; Mycobacterium avium-intracellulare Infection; Stavudine; United States; United States Food and Drug Administration | 1995 |
Advances in prevention and treatment of MAC.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Clinical Trials as Topic; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin | 1995 |
Hold the big MAC.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Zidovudine | 1996 |
Macrolides, azalides, and streptogrammins.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin | 1996 |
Progress report: prophylaxis and therapy for MAC.
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
MAC prophylaxis revisited.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
High-dose clarithromycin should be avoided.
Topics: Acquired Immunodeficiency Syndrome; Clarithromycin; Dose-Response Relationship, Drug; Humans; Mycobacterium avium-intracellulare Infection | 1996 |
Pot shots.
Topics: Acetylcysteine; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Antiviral Agents; Cattle; CD4 Lymphocyte Count; China; Clarithromycin; Clinical Trials as Topic; Clofazimine; Cryptosporidiosis; Drug Combinations; Ethambutol; Expectorants; Glutathione; Hepatitis B; Humans; Immunoglobulins; Interferon-alpha; Italy; Leprostatic Agents; Mycobacterium avium-intracellulare Infection; Philippines; Protease Inhibitors; Survival Rate; Taiwan; Thymosin; Zidovudine | 1996 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine | 1996 |
Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antifungal Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Dexamethasone; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Fluconazole; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Risk Factors; Uveitis | 1996 |
OIs and cancers.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Homosexuality, Male; Humans; Male; Mycobacterium avium-intracellulare Infection; Nitrates; Saliva; Sarcoma, Kaposi; Semen | 1999 |
[Effect of clarithromycin on monocyte-derived inflammatory cytokine production in bacterial infections with special reference to Mycobacterium avium infection].
Topics: Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Cytokines; Humans; Inflammation Mediators; Monocytes; Mycobacterium avium; Mycobacterium avium-intracellulare Infection | 2001 |
Surgery for Mycobacterium avium complex lung disease in the clarithromycin era.
Topics: Adult; Aged; Antibiotic Prophylaxis; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Pneumonia, Bacterial; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome | 2002 |
Uveitis associated with rifabutin therapy.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Arthritis; Atropine; Clarithromycin; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; Uveitis, Anterior | 1995 |
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linezolid; Male; Mefloquine; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Quinolines | 2002 |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Bacteremia; Cause of Death; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Pilot Projects | 1992 |
Clarithromycin-induced thrombocytopenia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Erythromycin; Humans; Male; Mycobacterium avium-intracellulare Infection; Thrombocytopenia | 1992 |
Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium.
Topics: Acquired Immunodeficiency Syndrome; Clarithromycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1992 |
Acquired resistance of MAI to clarithromycin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1992 |
Clarithromycin monotherapy of MAC-mycobacteriosis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Clarithromycin; Erythromycin; Humans; Mycobacterium avium-intracellulare Infection | 1991 |
Promising investigational drug available to AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Clarithromycin; Drugs, Investigational; Erythromycin; HIV-1; Humans; Mycobacterium avium-intracellulare Infection; Opportunistic Infections | 1991 |
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Erythromycin; Humans; In Vitro Techniques; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifamycins; Sulfisoxazole | 1990 |
In vitro and in vivo activities of clarithromycin against Mycobacterium avium.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1989 |